Pascal Deschatelets - 17 Jun 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Scientific Officer
Signature
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
Issuer symbol
APLS
Transactions as of
17 Jun 2022
Net transactions value
+$88,123
Form type
4
Filing time
22 Jun 2022, 16:32:06 UTC
Previous filing
09 Jun 2022
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $88,123 +33,005 +3.7% $2.67* 931,280 17 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -33,005 -9.5% $0.000000 313,494 17 Jun 2022 Common Stock 33,005 $2.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise from 10B5-1 trading plan.
F2 This stock option was granted on 12/5/2013 and is fully vested.